📰 Genome Engineering News
Page 6 - Genome Engineering News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genome Engineering. Real-time updates on events, politics, business and more.
January 27, 2022
Genome Editing/Genome Engineering Market worth $11.7 billion by 2026 – Emerging Trends, Innovations, Key Industry Insights and Opportunities
January 20, 2022
The genome editing market size to reach US$ 16.98 billion by 2028 from US$ 5.19 billion in 2021 to grow at a CAGR of 18.4% during 2021–2028....
November 23, 2021
250 Pages Cas9 Nuclease Market Survey by Fact MR, A Leading Business and Competitive Intelligence ProviderCas9 nuclease is CRISPR associated protein 9 is a bacterial immune defence nuclease protein which functions with Repetitive DNA sequences CRISPR. It is heavily utilized in genetic engineering applications to cle...
October 28, 2021
The growth of the building and construction sector complements the demand for Geosynthetic materials to be used in these applications driving the global Geosynthetics Market. JERSEY CITY
October 28, 2021
/PRNewswire/ -- Verified Market Research recently published a report, "Geosynthetics Market" By Function (Separation, Drainage, Filtration), By Application...
October 25, 2021
The latest advances in Gene Editing & CRISPR technology. Discover exclusive interviews and free resource
August 10, 2021
Company On-track to Submit First IND for BEAM-101 in the Second Half of 2021 Continued Progress Across Base Editing Portfolio, Including Initiation of...
June 9, 2021
MIT neuroscientist Guoping Feng has developed a new gene-editing method that may lead to the development of safer, more efficient gene therapies.
May 24, 2021
The Factors such as a wide range of applications of synthetic biology, the rising R&D funding and growing initiatives in synthetic biology, declining cost of DNA sequencing and synthesizing, and increasing investments in the market are propelling the growth of this market. However, biosafety, biosecurity, and ethical concerns related to synthetic biology would hamper the growth of this market. The oligonucleotides and synthetic DNA segment accounted for the largest share of the tool segment in ...
May 15, 2021
A groundbreaking study led by engineering and medical researchers at the University of Minnesota Twin Cities shows how engineered immune cells used in new cancer therapies can overcome physical barriers to allow a patient's own immune system to fight tumors.